Evolus, Inc. (LON:0K16)
14.58
+0.27 (1.87%)
Jan 31, 2025, 6:17 PM BST
Evolus Revenue
Evolus had revenue of $61.09M USD in the quarter ending September 30, 2024, with 22.12% growth. This brings the company's revenue in the last twelve months to $248.33M, up 34.43% year-over-year. In the year 2023, Evolus had annual revenue of $202.09M with 35.98% growth.
Revenue (ttm)
$248.33M
Revenue Growth
+34.43%
P/S Ratio
n/a
Revenue / Employee
$909.62K
Employees
273
Market Cap
700.77M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Evolus News
- 15 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Nasdaq Jumps 100 Points; Charles Schwab Profit Beats Estimates - Benzinga
- 4 weeks ago - Crude Oil Down 2%; D.R. Horton Earnings Top Views - Benzinga
- 4 weeks ago - Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why - Investor's Business Daily
- 4 weeks ago - Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday - Benzinga
- 4 weeks ago - Evolus announces Q4 preliminary unaudited net revenue of $79M - Seeking Alpha
- 4 weeks ago - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company's Guidance - Business Wire
- 5 weeks ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire